Skip to content
Screener

Thermo Fisher Scientific TMO Gross Profit

Discontinued — last reported Q1 '18

Gross Profit at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.15B+15.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
GLW
CorningGLW
$1.63B+17.0%
Revvity logo
RevvityRVTY
$387.66M+3.2%
Kewaunee Scientific Corporation logo
Kewaunee Scientific CorporationKEQU
$21.25M-11.6%
Danaher logo
DanaherDHR
$3.61B+2.5%

Other financials

Income statement

See full
Revenue$12.0B—
Operating income$2.1B—
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.42B+21.1%
Enterprise value$248.54B+18.9%
P/E30.6×+3.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Calculated from Thermo Fisher Scientific’s reported figures.

$5.9Btotal revenue−$2.3Btotal cost of revenue=$3.53B

The source filing: Thermo Fisher Scientific’s 10-K, filed February 26, 2020. Open the filing →

Filed
Feb 25, 2020, 7:00 PM EST
Fiscal year
FY2019
Accession
0000097745-20-000009

FAQ

What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.